Showing results (41-50 of 55) with videos related to
Sort By:
Pageof 6
Clinical Pharmacology and Therapeutics|September 1, 1994
P450 3A activity and cyclosporine dosing in kidney and heart transplant recipientsD K Turgeon, A B Leichtman, K S Lown, et al.Transplantation|June 27, 1994
Prediction of interpatient and intrapatient variation in OG 37-325 dosing requirements by the erythromycin breath test. A prospective study in renal transplant recipientsD K Turgeon, A B Leichtman, D S Blake, et al.Journal of Clinical Microbiology|May 3, 2013
Comparison of a real-time PCR method with serology and blood smear analysis for diagnosis of human anaplasmosis: importance of infection time course for optimal test utilizationA M Schotthoefer, J K Meece, L C Ivacic, et al.Thrombosis Research|April 1, 1990
Insulin, cortisol and catecholamines do not regulate circadian variations in fibrinolytic activityW L Chandler, D Mornin, R O Whitten, et al.Gastroenterology|December 1, 1993
Shiga-like toxin-producing Escherichia coli in Seattle children: a prospective studyT N Bokete, C M O'Callahan, C R Clausen, et al.Clinical Pharmacology and Therapeutics|September 1, 1992
Comparison of urinary 6-beta-cortisol and the erythromycin breath test as measures of hepatic P450IIIA (CYP3A) activityP B Watkins, D K Turgeon, P Saenger, et al.Endodontics & Dental Traumatology|February 1, 1995
Effect of bisphosphonates and gallium on dentin resorption in vitroF R Liewehr, D W Craft, P D Primack, et al.The Journal of Infectious Diseases|June 1, 1997
Genetic and phenotypic analysis of Escherichia coli with enteropathogenic characteristics isolated from Seattle childrenT N Bokete, T S Whittam, R A Wilson, et al.The Journal of Infectious Diseases|May 12, 2007
Impact of drug-exposure intensity and duration of therapy on the emergence of Staphylococcus aureus resistance to a quinolone antimicrobialV H Tam, A Louie, T R Fritsche, et al.Journal of Clinical Microbiology|December 17, 1997
Detection of immunoglobulin G (IgG) and IgM antibodies to Toxoplasma gondii: evaluation of four commercial immunoassay systemsW T Hofgärtner, S R Swanzy, R M Bacina, et al.Pageof 6